Links

Last minute


Achillion Announces Additional Proof-of-Concept Data With ACH-2684 for the ...
MarketWatch (press release)
NEW HAVEN, Conn., May 21, 2012 (GlobeNewswire via COMTEX) -- Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) today reported proof-of-concept data from a Phase 1b clinical trial demonstrating that patients with chronic hepatitis C (HCV) genotype 1 (GT 1) ...
Achillion Announces Executive PromotionPharmaLive.com (press release)

all 7 news articles »

Percutaneous Tibial Nerve Stimulation Included in the American Urological ...
MarketWatch (press release)
The AUA's evidence-based guidelines are intended to promote the highest standards of clinical care. Uroplasty's UrgentĀ® PC Neuromodulation System is the only FDA cleared device that delivers PTNS. "It is noteworthy that the world's most prestigious ...
Uroplasty Announces Percutaneous Tibial Nerve Stimulation Included in the ...Benzinga

all 4 news articles »

Marina Biotech and Girindus Group Announce Strategic Alliance
MarketWatch (press release)
"Our mission here at Marina is to conduct basic research in the application of oligonucleotide-based therapeutics to treat human disease as well as to advance those therapeutics through preclinical and clinical development and ultimately to the market.

and more »